Artelo Biosciences Inc (ARTL) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Artelo Biosciences Inc   (NASDAQ: ARTL)


Artelo Biosciences Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Artelo Biosciences Inc 's ROA in the second quarter of 2026?
Artelo Biosciences Inc recorded a cumulative net loss of $-13 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -167.59%.

However, within the Healthcare sector 849 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4514, from total ROA ranking in the first quarter of 2026 at 5295.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 48.24 % 375.56 % -40.38 % -40.2 % -47.67 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -13 -13 -13 -12 -11
Return On Assets (TTM) -167.59 % -191.39 % -344.82 % -296.75 % -213.19 %
ARTL's Total Ranking # 4514 # 5295 # 4692 # 4688 # 4695
Total Assets (TTM) in million 6 17 3 4 4
Seq. Total Assets Change -61.36 % 496.79 % -34.36 % -2.07 % 23.95 %
Seq. Net Income Change - - - - -

ARTL's 5 Years Annual ROA >> Back to ARTL Management Effectiveness >> Compare ARTL ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 403
Sector # 850
Overall # 4435

Return On Assets Statistics
High Average Low
-11 %
-185.48 %
-668.19 %
(Aug 31 2017)   (Nov 30 2016)



  News about Artelo Biosciences Inc Return on Assets ROA

Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing

Artelo Biosciences: Navigating Financial Challenges Amid Promising Clinical DevelopmentsIntroductionArtelo Biosciences, Inc. (Nasdaq: ARTL) recently announced a private placement financing round that raised approximately $1.425 million. This capital injection comes at a time when the clinical-stage pharmaceutical company faces significant financial hurdles characterized by a net loss of $10 million within the last year and a staggering negative return on assets (ROA) of -164.14% as of the first quarter of 2025. However, the company s robust clinical trial data for ART27.13, a treatment targeting cancer-related anorexia, offers a glimmer of hope amid its financial woes.Key Developments: Financing and Financial Health1. At-the-Market Private Placement: On June 26, 2025, Artelo Biosciences announced a definitive securities purchase agreement for an At-the-Market private placement, successfully securing $1.425 million. This financing will be crucial for sustaining operations as the company looks to advance its clinical pipeline.



Financial Statements
Artelo Biosciences Inc 's Assets $ 6 million ARTL's Balance sheet
Artelo Biosciences Inc 's Income $ -2 million Quarterly ARTL's Income Statement
ARTL's Income by Division See ARTL's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Aug 31 2021)
FY 2021
Y / Y Total Assets Change -40.38 % -63.98 % -36.14 % 61.65 % 188.68 %
Total Assets in million 3 5 13 20 13
Y / Y Net Income Change - - - - -
Net Income in million -13 -10 -9 -10 -7
Annual Return On Assets -459.8 % -209.15 % -71.22 % -49.37 % -58.86 %

ARTL's 5 Years Annual ROA >> Back to ARTL Management Effectiveness >> Compare ARTL ROA to its Competitors



More Return On Assets Ratios
ARTL's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ARTL's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ARTL's Competitors
Subscribers only: Roa for Artelo Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for ARTL's Customers

You may also want to know
ARTL's Roi ARTL's Inventory Turnover Ratio ARTL's Growth Rates ARTL's Dividend Comparisons
ARTL's Profitability Ratios ARTL's Asset Turnover Ratio ARTL's Dividend Growth
ARTL's Roe ARTL's Valuation Ratios ARTL's Financial Strength Ratios ARTL's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-12T06:12:02+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.